enVVeno Medical Corp reports results for the quarter ended in March - Earnings Summary

• enVVeno Medical Corp NVNO reported a quarterly adjusted loss of 31 cents​​ per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of -57 cents. The lone analyst forecast for the quarter was for a loss of 40 cents per share.

• Reported revenue was zero​; analysts expected zero.

• enVVeno Medical Corp's reported EPS for the quarter was a loss of 31 cents​.

• The company reported a quarterly loss of $4.99 million.

• enVVeno Medical Corp shares had fallen by 8.6% this quarter and lost 3.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 4.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "strong buy"

Wall Street's median 12-month price target for enVVeno Medical Corp is $20.40

This summary was machine generated from LSEG data May 11 at 12:02 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)